Eagle Pharmaceuticals Total Assets 2013-2019 | EGRX

Eagle Pharmaceuticals total assets from 2013 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Eagle Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $255
2018 $239
2017 $270
2016 $214
2015 $125
2014 $50
2014 $53
2013 $18
2012 $6
2012 $9
2011 $9
Eagle Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2019-12-31 $255
2019-09-30 $257
2019-06-30 $262
2019-03-31 $259
2018-12-31 $239
2018-09-30 $269
2018-06-30 $274
2018-03-31 $249
2017-12-31 $270
2017-09-30 $267
2017-06-30 $220
2017-03-31 $225
2016-12-31 $214
2016-09-30 $147
2016-06-30 $149
2016-03-31 $129
2015-12-31 $125
2015-09-30 $122
2015-06-30 $121
2015-03-31 $130
2014-12-31 $50
2014-09-30 $53
2014-06-30 $58
2014-03-31 $64
2013-12-31 $0
2013-09-30 $18
2013-06-30 $0
2013-03-31 $0
2012-09-30 $9
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.647B $0.196B
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.889B 25.53
Medtronic (MDT) Ireland $126.096B 16.95
Stryker (SYK) United States $62.094B 20.06
Boston Scientific (BSX) United States $45.907B 20.68
Baxter (BAX) United States $43.082B 26.29
Coloplast (CLPBY) Denmark $31.666B 48.87
Lonza Group Ag (LZAGY) Switzerland $30.808B 0.00
Terumo (TRUMY) Japan $25.125B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.988B 0.00
ResMed (RMD) United States $22.893B 39.77
Zimmer Biomet Holdings (ZBH) United States $20.215B 12.44
Smith & Nephew SNATS (SNN) United Kingdom $15.935B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $11.410B 53.33
Insulet (PODD) United States $10.806B 661.15
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.302B 21.00
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
Perrigo (PRGO) Ireland $6.476B 11.80
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Haemonetics (HAE) United States $5.142B 31.65
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Canopy Growth (CGC) Canada $5.010B 0.00
ICU Medical (ICUI) United States $4.301B 28.09
Quidel (QDEL) United States $4.034B 35.41
Neogen (NEOG) United States $3.598B 60.95
Agios Pharmaceuticals (AGIO) United States $2.706B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.438B 0.00
NuVasive (NUVA) United States $2.419B 18.71
Envista Holdings (NVST) United States $2.275B 0.00
National Vision Holdings (EYE) United States $1.476B 24.86
AtriCure (ATRC) United States $1.368B 0.00
Cardiovascular Systems (CSII) United States $1.302B 0.00
TG Therapeutics (TGTX) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.986B 19.50
Aurora Cannabis (ACB) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.921B 0.00
VAREX IMAGING (VREX) United States $0.835B 17.34
Aphria (APHA) $0.802B 0.00
Cerus (CERS) United States $0.788B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.757B 136.15
Omeros (OMER) United States $0.752B 0.00
InMode (INMD) Israel $0.709B 0.00
OraSure Technologies (OSUR) United States $0.689B 85.46
PetIQ (PETQ) United States $0.675B 18.38
Quanterix (QTRX) United States $0.596B 0.00
LeMaitre Vascular (LMAT) United States $0.490B 27.59
Surmodics (SRDX) United States $0.455B 52.30
Lantheus Holdings (LNTH) United States $0.440B 9.90
Owens & Minor (OMI) United States $0.427B 11.67
Meridian Bioscience (VIVO) United States $0.380B 15.31
Zynex (ZYXI) United States $0.371B 39.96
Vapotherm (VAPO) United States $0.367B 0.00
Repro-Med Systems (KRMD) United States $0.337B 212.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Organigram Holdings (OGI) Canada $0.296B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.220B 0.00
BioLife Solutions (BLFS) United States $0.210B 128.63
Female Health (VERU) United States $0.203B 0.00
HEXO (HEXO) $0.197B 0.00
InfuSystems Holdings (INFU) United States $0.191B 159.67
Exagen (XGN) United States $0.170B 0.00
Viemed Healthcare (VMD) United States $0.169B 19.13
Rockwell Medical (RMTI) United States $0.144B 0.00
United Health Products (UEEC) United States $0.140B 0.00
Evolus (EOLS) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.107B 0.00
Fonar (FONR) United States $0.097B 7.08
Chimerix (CMRX) United States $0.086B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
MTech Acquisition (KERN) United States $0.079B 0.00
United-Guardian (UG) United States $0.063B 13.17
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00